Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Dinaciclib | Cyclin-dependent Kinase Inhibitors: R&D Systems
Cyclin-dependent kinase inhibitor dinaciclib interacts with the acetyl ...
Cyclin-Dependent Kinase Inhibitor Dinaciclib Interacts with the Acetyl ...
Frontiers | Dinaciclib as an effective pan-cyclin dependent kinase ...
美国APExBIO中文官网 - Dinaciclib (SCH727965)|Potent CDK inhibitor|CAS# 779353 ...
Cyclin-dependent kinase inhibitor Dinaciclib (SCH727965) inhibits ...
Dinaciclib (SCH 727965), a Novel and Potent Cyclin-Dependent Kinase ...
The CDK Inhibitor Dinaciclib Improves Cisplatin Response in ...
Dinaciclib | C21H28N6O2 | CID 46926350 - PubChem
Dinaciclib Interrupts Cell Cycle and Induces Apoptosis in Oral Squamous ...
Multiple CDK inhibitor dinaciclib suppresses neuroblastoma growth via ...
Dinaciclib (SCH 727965) | CDK2/5/9 Inhibitor | MedChemExpress
CDK2/Cyclin-E1 bound to CDK-Inhibitor Dinaciclib - 3D model by ashleyrh ...
Dinaciclib | CAS 779353-01-4 | SCBT - Santa Cruz Biotechnology
Cyclin-dependent kinase inhibitor dinaciclib potently synergizes with ...
A cyclin-dependent kinase inhibitor, dinaciclib in preclinical ...
Inhibition of cyclin dependent kinase 9 by dinaciclib suppresses cyclin ...
Synthetic lethality of cyclin-dependent kinase inhibitor Dinaciclib ...
Dinaciclib Induces Anaphase Catastrophe in Lung Cancer Cells via ...
DINACICLIB (SCH727965) INHIBITS THE UNFOLDED PROTEIN RESPONSE (UPR ...
The Cdk inhibitor dinaciclib as a promising anti-tumorigenic agent in ...
(PDF) Dinaciclib is a Novel Cyclin Dependent Kinase Inhibitor with ...
(PDF) Dinaciclib as an effective pan-cyclin dependent kinase inhibitor ...
(PDF) A cyclin-dependent kinase inhibitor, dinaciclib in preclinical ...
The multi-CDK inhibitor dinaciclib reverses bromo- and extra-terminal ...
Anti-Tumor and Chemosensitizing Effects of the CDK Inhibitor Dinaciclib ...
(PDF) Cyclin-dependent kinase inhibitor dinaciclib potently synergizes ...
Dinaciclib Is a Transcriptional CDK Inhibitor That Reduces Expression ...
(PDF) Cyclin-Dependent Kinase Inhibitor Dinaciclib Interacts with the ...
Dinaciclib Is a Potent Inhibitor of CDK12 in Addition to CDK9 ...
Dinaciclib (CAS 779353-01-4) | Glentham Life Sciences
Characterization of Inhibitor Binding to CDK1 (A) Dinaciclib binds to ...
CDK9 inhibition by dinaciclib potently suppresses Mcl-1 to induce ...
Dinaciclib inhibits cyclin B1 via targeting CDK9-cMYC axis. Western ...
Crystal structures of dinaciclib bound to CDK2 and BRDT | Download ...
Dinaciclib sensitizes cyclin E1-driven ovarian cancers to cisplatin ...
Dinaciclib - (CAS 779353-01-4) - Products - BOC Sciences
Synthetic Approaches and Clinical Application of Representative Small ...
Clinical and laboratory studies of the novel cyclin-dependent kinase ...
Cyclin-dependent kinase inhibitors exert distinct effects on patient ...
The Renaissance of Cyclin Dependent Kinase Inhibitors
Phase 1 safety, pharmacokinetic and pharmacodynamic study of the cyclin ...
RCSB PDB - 5L2W: The X-ray co-crystal structure of human CDK2/CyclinE ...
The anti-melanoma activity of dinaciclib, a cyclin-dependent kinase ...
Inhibitory Response to CK II Inhibitor Silmitasertib and CDKs Inhibitor ...
Oncology Reports
Spectrum and Degree of CDK Drug Interactions Predicts Clinical ...
Structure of dinaciclib. | Download Scientific Diagram
Dinaciclib, a Cyclin-Dependent Kinase Inhibitor Promotes Proteasomal ...
Initial Testing (Stage 1) of the Cyclin Dependent Kinase Inhibitor SCH ...
Selective targeting of Cyclin E1 amplified high grade serous ovarian ...
Dinaciclib, a novel CDK inhibitor, demonstrates encouraging single ...
PPT - Le dinaciclib, un inhibiteur de kinase cycline dépendante ...
CDK9 inhibition as an effective therapy for small cell lung cancer - PMC
Author Correction: Pre-therapeutic efficacy of the CDK inhibitor ...
Full article: Synthetic lethality of cyclin-dependent kinase inhibitor ...
(PDF) A Cyclin-Dependent Kinase Inhibitor, Dinaciclib, Impairs ...
(PDF) Phase 1 safety, pharmacokinetic and pharmacodynamic study of the ...